Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel

医学 杜鲁特格拉维尔 重症监护医学 不利影响 梅德林 抗逆转录病毒疗法 家庭医学 病毒载量 人类免疫缺陷病毒(HIV) 药理学 政治学 法学
作者
Rajesh Tim Gandhi,Raphael J. Landovitz,Paul Edward Sax,Davey M. Smith,Sandra Ann Springer,Huldrych F. Günthard,Melanie Thompson,Roger Bedimo,Constance Ann Benson,Susan Buchbinder,Brenda Crabtree‐Ramírez,Carlos del Río,Ellen Eaton,Joseph J. Eron,Jennifer Hoy,Clara Lehmann,Jean‐Michel Molina,Donna M. Jacobsen,Michael S. Saag
出处
期刊:JAMA [American Medical Association]
卷期号:333 (7): 609-609 被引量:340
标识
DOI:10.1001/jama.2024.24543
摘要

Importance: New data and new antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Objective: To provide updated recommendations for HIV treatment and clinical management and HIV prevention. Methods: A panel of volunteer expert physician scientists were appointed to provide updated consensus recommendations for 2024. Relevant evidence in the literature since the last report was identified from PubMed and Embase searches (which initially yielded 3998 unique citations, of which 249 were considered relevant); from ongoing monitoring of the literature by the panel members; from data submitted by product manufacturers; and from studies presented at peer-reviewed scientific conferences between June 2022 and October 2024. Findings: Antiretroviral therapy continues to be recommended for all individuals with HIV. For most people with HIV, initial regimens composed of an integrase strand transfer inhibitor (InSTI), specifically bictegravir or dolutegravir, with 2 (and in some cases 1) nucleoside or nucleotide reverse transcriptase inhibitors are recommended. Recommendations are made for those with particular clinical circumstances, such as pregnancy and active opportunistic diseases, as well as for those unable to take InSTIs. Regimens may need to be changed for virologic failure, adverse effects, convenience, or cost, among other reasons. Long-acting injectable therapy is available for those who prefer not to take daily oral medications and for people struggling with adherence to daily therapy. Recommendations are provided for laboratory monitoring, management of substance use disorders and weight changes, as well as use of statins for cardiovascular disease prevention. For HIV prevention, oral (daily or intermittent) and injectable long-acting medications are effective options for people at increased likelihood of HIV exposure. Further, new tools for maintaining health and well-being among people with HIV, such as doxycycline postexposure prophylaxis to avert sexually transmitted infection, and strategies to treat substance use disorders, are recommended. Disparities in HIV acquisition and care access are discussed and solutions proposed. Conclusions: New approaches for treating and preventing HIV offer additional tools to help end the HIV epidemic, but achieving this goal depends on addressing disparities and inequities in access to care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
顺心的大碗完成签到 ,获得积分10
1秒前
June17完成签到,获得积分10
1秒前
称心的乐巧完成签到,获得积分10
2秒前
2秒前
Hello的应助被烊烊采纳,获得10
2秒前
搜集达人的应助被katha采纳,获得10
2秒前
V1G1L完成签到,获得积分10
2秒前
ding的应助被Lifel采纳,获得10
3秒前
十八与雨完成签到,获得积分10
3秒前
3秒前
大个的应助被负责银耳汤采纳,获得10
3秒前
ws完成签到,获得积分10
3秒前
3秒前
长生久视完成签到,获得积分10
4秒前
joy发布了新的文献求助10
4秒前
蒋老黑发布了新的文献求助10
4秒前
5秒前
5秒前
5秒前
申屠发布了新的文献求助10
5秒前
5秒前
5秒前
lyy发布了新的文献求助10
5秒前
5秒前
其实发布了新的文献求助10
5秒前
Zoey完成签到 ,获得积分20
6秒前
6秒前
桐桐的应助被初景采纳,获得30
6秒前
可爱的函函的应助被blingbling采纳,获得10
6秒前
6秒前
彭于彦祖的应助被lulululu采纳,获得50
6秒前
Eviyen发布了新的文献求助20
6秒前
羔羔羊发布了新的文献求助30
7秒前
秋风的应助被激你肽酶采纳,获得10
7秒前
Henry发布了新的文献求助10
7秒前
7秒前
领导范儿的应助被英勇的若灵采纳,获得10
7秒前
图图完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8155816
求助须知:如何正确求助?哪些是违规求助? 9552109
关于积分的说明 21708107
捐赠科研通 7744978
什么是DOI,文献DOI怎么找? 3426225
关于科研通互助平台的介绍 2551237
邀请新用户注册赠送积分活动 2469958